Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.28B |
| FY2017, ended Dec 31, 2017 | $7.34B |
| FY2018, ended Dec 31, 2018 | $12.0B |
| FY2019, ended Dec 31, 2019 | $18.4B |
| FY2020, ended Dec 31, 2020 | $24.2B |
| FY2021, ended Dec 31, 2021 | $57.8B |
| FY2022, ended Dec 31, 2022 | $38.3B |
| FY2023, ended Dec 31, 2023 | $44.7B |
| FY2024, ended Dec 31, 2024 | $72.7B |
| FY2025, ended Dec 31, 2025 | $58.8B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $113B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.28B |
| FY2017, ended Dec 31, 2017 | $1.49B |
| FY2018, ended Dec 31, 2018 | $1.80B |
| FY2019, ended Dec 31, 2019 | $2.16B |
| FY2020, ended Dec 31, 2020 | $2.59B |
| FY2021, ended Dec 31, 2021 | $3.34B |
| FY2022, ended Dec 31, 2022 | $4.42B |
| FY2023, ended Dec 31, 2023 | $5.30B |
| FY2024, ended Dec 31, 2024 | $5.96B |
| FY2025, ended Dec 31, 2025 | $6.80B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $7.53B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $32.2M | $279M |
| FY2017, ended Dec 31, 2017 | $31.4M | $459M |
| FY2018, ended Dec 31, 2018 | $335M | $586M |
| FY2019, ended Dec 31, 2019 | $332M | $716M |
| FY2020, ended Dec 31, 2020 | $489M | $958M |
| FY2021, ended Dec 31, 2021 | $607M | $1.20B |
| FY2022, ended Dec 31, 2022 | $857M | $1.45B |
| FY2023, ended Dec 31, 2023 | $1.15B | $1.73B |
| FY2024, ended Dec 31, 2024 | $1.75B | $1.88B |
| FY2025, ended Dec 31, 2025 | $1.85B | $2.23B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.12B | $3.12B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $709M |
| FY2017, ended Dec 31, 2017 | $811M |
| FY2018, ended Dec 31, 2018 | $1.11B |
| FY2019, ended Dec 31, 2019 | $1.22B |
| FY2020, ended Dec 31, 2020 | $1.06B |
| FY2021, ended Dec 31, 2021 | $1.32B |
| FY2022, ended Dec 31, 2022 | $1.68B |
| FY2023, ended Dec 31, 2023 | $1.40B |
| FY2024, ended Dec 31, 2024 | $2.88B |
| FY2025, ended Dec 31, 2025 | $2.50B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.93B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | — |
| FY2020, ended Dec 31, 2020 | $0 |
| FY2021, ended Dec 31, 2021 | $988M |
| FY2022, ended Dec 31, 2022 | $990M |
| FY2023, ended Dec 31, 2023 | $992M |
| FY2024, ended Dec 31, 2024 | $994M |
| FY2025, ended Dec 31, 2025 | $996M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $497M |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 16.3% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 877M |
| FY2017, ended Dec 31, 2017 | 840M |
| FY2018, ended Dec 31, 2018 | 853M |
| FY2019, ended Dec 31, 2019 | 863M |
| FY2020, ended Dec 31, 2020 | 816M |
| FY2021, ended Dec 31, 2021 | 804M |
| FY2022, ended Dec 31, 2022 | 784M |
| FY2023, ended Dec 31, 2023 | 763M |
| FY2024, ended Dec 31, 2024 | 769M |
| FY2025, ended Dec 31, 2025 | 740M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 734M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $111M | $122M | $44.8M |
| FY2017, ended Dec 31, 2017 | $446M | $137M | $75.8M |
| FY2018, ended Dec 31, 2018 | $212M | $163M | $86.5M |
| FY2019, ended Dec 31, 2019 | $145M | $174M | $49.5M |
| FY2020, ended Dec 31, 2020 | $1.08B | $192M | $22.1M |
| FY2021, ended Dec 31, 2021 | $742M | $208M | $26.0M |
| FY2022, ended Dec 31, 2022 | $1.99B | $217M | $26.1M |
| FY2023, ended Dec 31, 2023 | $1.50B | $249M | $43.8M |
| FY2024, ended Dec 31, 2024 | $600K | $258M | $63.1M |
| FY2025, ended Dec 31, 2025 | $2.29B | $280M | $44.7M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.86B | $296M | $75.7M |
Valuation
At current price- Market Cap
- $136B
- P/E
- 64.0×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 18.0×
- Price / Book
- 87.5×
- EV / EBITDA
- 51.2×
Growth
Trailing 12 months- Revenue (TTM)
- $7.53B
- Revenue Growth YoY
- 18.8%
- Revenue CAGR 3Y
- 15.5%
- Revenue CAGR 5Y
- 21.3%
- EPS Growth YoY
- 12.7%
- Net Income Growth YoY
- 9.3%
Profitability
Trailing 12 months- Gross Margin
- 80.2%
- Operating Margin
- 32.4%
- Net Margin
- 28.2%
- FCF Margin
- 41.4%
- Return on Equity
- 117%
Earnings
Trailing 12 months- Net Income
- $2.12B
- EPS (diluted)
- $2.83
- EBITDA
- $2.60B
- Operating Income
- $2.44B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $2.93B
- Total Debt
- $497M
- Net Cash
- $2.44B
- Total Assets
- $10.9B
- Total Liabilities
- $9.31B
- Shareholders' Equity
- $1.55B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.40B
- Capital Expenditure
- $279M
- Free Cash Flow
- $3.12B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.03
Every ratio is calculated from the company’s reported figures.